Which Indian companies may hit hard if Trump announces tariffs on pharma

Quick Summary:

In March, he had said that tariffs on pharmaceutical imports would be announced “at some point in the not too distant future.

Biocon, Laurus Labs, and Lupin were the worst hit, with their shares falling between 3 per cent and 5 per cent.

According to the reports, if these new tariffs are introduced, they could hit Indian pharmaceutical companies hard.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: BusinessFinance

Markets: India

Topics: US-India pharma trade Pharmaceutical trade policy Trump reciprocal tariffs Trump on medicine production Lupin US sales US pharmaceutical imports Indian pharma stocks fall Laurus Labs Sun Pharma US market India US medicine tariffs Aurobindo Pharma export Trump pharma tariffs Indian drugmakers Biocon US revenue Generic drug exports to US

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2025-04-09 @ 17:07:19 (6 days ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 477 words

Reading Time: 3 minutes read

Sentences: 24 lines

Sentence Length: 20 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 27754594

View Article Analysis

About Business Standard

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 252 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 2 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions